|
Press Release Newly-Unsealed Documents Shed Light on Abbott Labs' 400% Norvir Price HikeUnion, Consumer Groups Decry Abbott for Putting Profits Before HIV/AIDS Patients' Needs
May 12, 2008 Boston, MA -- In an ongoing nationwide class action lawsuit against Abbott Laboratories, Inc. (NYSE: ABT), the Court in the case recently ordered the unsealing of documents regarding Abbott's four-hundred percent price increase of the HIV/AIDS drug NorvirĀ®. Abbott fought to keep these documents sealed, arguing that they contain 'business strategies' important to Abbott's competitive position in the HIV pharmaceutical market. But Judge Claudia Wilken ruled that because the price increase related to the "allegations that are central to Plaintiff's anti-trust claims" the documents should be unsealed. (Order, p. 3). View Full Article
Comment by: DAVID MONDEJAR
(KINGSTON,, NY 12401)
Sat., Sep. 13, 2008 at 11:29 pm EDT What everyone suspected has just proven to be true! These big pharmaceutical companies could care less about researching a cure, they make millions of dollars keeping people on "Maintenance drugs". Corporate "Greed" in this country has gone out of control and I will live to see the day when the big "backlash" comes!
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.) |
|